High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of staphylococcus aureus

Journal of Investigative Dermatology

Volumn 133, Issue 3, 2013, Pages 847-850

  Van Der Kooi Pol, Magdalena M ^a   De Vogel, Corné P ^b   Westerhout Pluister, Gerlinde N ^c   Veenstra Kyuchukova, Yanka K ^a   Duipmans, José C ^a   Glasner, Corinna ^a   Buist, Girbe ^a   Elsinga, Goffe S ^d   Westra, Hans ^d   Bonarius, Hendrik P J ^d   Groen, Herman ^d   Van Wamel, Willem J B ^b   Grundmann, Hajo ^a,c   Jonkman, Marcel F ^a   Van Dijl, Jan Maarten ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d IQ Therapeutics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; STAPHYLOCOCCAL ENTEROTOXIN M; STAPHYLOCOCCUS ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN N; STAPHYLOCOCCUS ENTEROTOXIN O; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBODY SPECIFICITY; ANTIBODY TITER; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BLISTER; BLOOD DONOR; BLOOD SAMPLING; CELLULAR IMMUNITY; DISEASE CARRIER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA; FURUNCULOSIS; HUMAN; IMMUNE RESPONSE; INFECTION SENSITIVITY; LETTER; NOSE SMEAR; PRIORITY JOURNAL; SKIN INJURY; STAPHYLOCOCCUS AUREUS; THROAT CULTURE; VARIABLE NUMBER OF TANDEM REPEAT; WOUND FLUID;

EID: 84873715003     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.347     Document Type: Letter

References (15)

1. Brandling-Bennett HA, Morel KD (2010) Common wound colonizers in patients with epidermolysis bullosa. Pediatr Dermatol 27: 25-8
2. Burian M, Grumann D, Holtfreter S et al. (2012) Expression of staphylococcal superantigens during nasal colonization is not sufficient to induce a systemic neutralizing antibody response in humans. Eur J Clin Microbiol Infect Dis 31: 251-6
3. Graber CJ, Shane AL, Weintrub P et al. (2011) Clonality of Staphylococcus aureus colonization over time in attendees of a camp for children with chronic dermatoses. Pediatr Dermatol 28: 519-23
4. Gravet A, Colin DA, Keller D et al. (1998) Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett 436: 202-8
5. Grumann D, Ruotsalainen E, Kolata J et al. (2011) Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia. Clin Vaccine Immunol 18: 487-93
6. Holtfreter S, Grumann D, Schmudde M et al. (2007) Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J Clin Microbiol 45: 2669-80
7. Holtfreter S, Jursa-Kulesza J, Masiuk H et al. (2011) Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 30: 707-17
8. Kolata J, Bode LG, Holtfreter S et al. (2011) Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non-carriers. Proteomics 11: 3914-27
9. Lorenz U, Lorenz B, Schmitter T et al. (2011) Functional antibodies targeting IsaA of Staphylococcus aureus augment host immune response and open new perspectives for antibacterial therapy. Antimicrob Agents Chemother 55: 165-73
10. Pope E, Lara-Corrales I, Mellerio J et al. (2012) A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol; e-pub ahead of print 1 March 2012
11. van der Kooi-Pol MM, Veenstra-Kyuchukova YK, Duipmans JC et al. (2012) High genetic diversity of Staphylococcus aureus strains colonizing patients with epidermolysis bullosa. Exp Dermatol 21: 463-6
12. Verkaik NJ, Boelens HA, de Vogel CP et al. (2010) Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 29: 509-18
13. Wertheim HF, Melles DC, Vos MC et al. (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5: 751-62
14. Wertheim HF, Vos MC, Ott A et al. (2004) Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus noncarriers. Lancet 364: 703-5
15. Ziebandt AK, Kusch H, Degner M et al. (2010) Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulation. Proteomics 10: 1634-44